{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:34:26Z","timestamp":1769204066676,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41388-018-0146-y","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T12:38:04Z","timestamp":1518611884000},"page":"2432-2443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression"],"prefix":"10.1038","volume":"37","author":[{"given":"J.","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-M.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.-Q.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"146_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","volume":"370","author":"R Hehlmann","year":"2007","unstructured":"Hehlmann R, Hochhaus A, Baccarani M, European L. Chronic myeloid leukaemia. Lancet. 2007;370:342\u201350.","journal-title":"Lancet"},{"key":"146_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini A, Thongjuea S, Barkas N, Woll PS, Povinelli BJ, Booth CAG, et al. Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med. 2017;23:692\u2013702.","journal-title":"Nat Med"},{"key":"146_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5:172\u201383.","journal-title":"Nat Rev Cancer"},{"key":"146_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc2368","volume":"8","author":"M Savona","year":"2008","unstructured":"Savona M, Talpaz M. Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer. 2008;8:341\u201350.","journal-title":"Nat Rev Cancer"},{"key":"146_CR5","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004;103:4010\u201322.","journal-title":"Blood"},{"key":"146_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1182\/blood-2015-05-646489","volume":"126","author":"W Wang","year":"2015","unstructured":"Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM, et al. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood. 2015;126:1699\u2013706.","journal-title":"Blood"},{"key":"146_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrclinonc.2016.13","volume":"13","author":"P Sidaway","year":"2016","unstructured":"Sidaway P. Haematological cancer: ponatinib in CML\u2014keeping PACE with multiple mutations. Nat Rev Clin Oncol. 2016;13:135.","journal-title":"Nat Rev Clin Oncol"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/gtmb.2012.0530","volume":"17","author":"Q Chen","year":"2013","unstructured":"Chen Q, Lin J, Qian J, Deng ZQ, Qian W, Yang J, et al. The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia. Genet Test Mol Biomark. 2013;17:508\u201311.","journal-title":"Genet Test Mol Biomark"},{"key":"146_CR9","first-page":"3848","volume":"60","author":"V Martelange","year":"2000","unstructured":"Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res. 2000;60:3848\u201355.","journal-title":"Cancer Res"},{"key":"146_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.leukres.2014.02.012","volume":"38","author":"J Lin","year":"2014","unstructured":"Lin J, Chen Q, Yang J, Qian J, Deng ZQ, Qian W, et al. DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia. Leuk Res. 2014;38:601\u20137.","journal-title":"Leuk Res"},{"key":"146_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2141.2012.09138.x","volume":"158","author":"Q Chen","year":"2012","unstructured":"Chen Q, Lin J, Yao DM, Qian J, Qian W, Yang J, et al. Aberrant hypomethylation of DDX43 promoter in myelodysplastic syndrome. Br J Haematol. 2012;158:293\u20136.","journal-title":"Br J Haematol"},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/sj.leu.2402732","volume":"16","author":"SP Adams","year":"2002","unstructured":"Adams SP, Sahota SS, Mijovic A, Czepulkowski B, Padua RA, Mufti GJ, et al. Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia. 2002;16:2238\u201342.","journal-title":"Leukemia"},{"key":"146_CR13","first-page":"8","volume":"10","author":"AP Liggins","year":"2010","unstructured":"Liggins AP, Lim SH, Soilleux EJ, Pulford K, Banham AH. A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. Cancer Immun. 2010;10:8.","journal-title":"Cancer Immun"},{"key":"146_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2013.01.033","volume":"333","author":"M Luo","year":"2013","unstructured":"Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333:213\u201321.","journal-title":"Cancer Lett"},{"key":"146_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0426-x","volume":"14","author":"A Conigliaro","year":"2015","unstructured":"Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90 + liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155.","journal-title":"Mol Cancer"},{"key":"146_CR16","doi-asserted-by":"publisher","first-page":"eaak9557","DOI":"10.1126\/scisignal.aak9557","volume":"10","author":"W Zhou","year":"2017","unstructured":"Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li LY, et al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b\/c and let-7b. Sci Signal. 2017;10:eaak9557.","journal-title":"Sci Signal"},{"key":"146_CR17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/onc.2011.408","volume":"31","author":"D Fanale","year":"2012","unstructured":"Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A. Breast cancer genome-wide association studies: there is strength in numbers. Oncogene. 2012;31:2121\u20138.","journal-title":"Oncogene"},{"key":"146_CR18","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.18632\/oncotarget.13708","volume":"8","author":"Q Wang","year":"2017","unstructured":"Wang Q, Cheng N, Li X, Pan H, Li C, Ren S, et al. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget. 2017;8:2558\u201367.","journal-title":"Oncotarget"},{"key":"146_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","volume":"161","author":"DF Lee","year":"2015","unstructured":"Lee DF, Su J, Kim HS, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240\u201354.","journal-title":"Cell"},{"key":"146_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","volume":"52","author":"AN Kallen","year":"2013","unstructured":"Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101\u201312.","journal-title":"Mol Cell"},{"key":"146_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1158\/0008-5472.CAN-12-2651","volume":"73","author":"J Cai","year":"2013","unstructured":"Cai J, Wu J, Zhang H, Fang L, Huang Y, Yang Y, et al. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res. 2013;73:756\u201366.","journal-title":"Cancer Res"},{"key":"146_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/onc.2015.84","volume":"35","author":"X Zhu","year":"2016","unstructured":"Zhu X, Shen H, Yin X, Long L, Xie C, Liu Y, et al. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin. Oncogene. 2016;35:323\u201332.","journal-title":"Oncogene"},{"key":"146_CR23","doi-asserted-by":"crossref","first-page":"25339","DOI":"10.18632\/oncotarget.4509","volume":"6","author":"J Zheng","year":"2015","unstructured":"Zheng J, Li XD, Wang P, Liu XB, Xue YX, Hu Y, et al. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget. 2015;6:25339\u201355.","journal-title":"Oncotarget"},{"key":"146_CR24","first-page":"113","volume":"62","author":"TJ Zhang","year":"2016","unstructured":"Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang L, Zhou JD, et al. Down-regulation of miR-186 correlates with poor survival in de novo acute myeloid leukemia. Clin Lab. 2016;62:113\u201320.","journal-title":"Clin Lab"},{"key":"146_CR25","first-page":"1171","volume":"19","author":"Q Chen","year":"2011","unstructured":"Chen Q, Lin J, Qian J, Yao DM, Qian W, Li Y, et al. Gene expression of helicase antigen in patients with acute and chronic myeloid leukemia. Zhongguo shi yan xue ye xue za zhi. 2011;19:1171\u20135.","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"146_CR26","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/jcp.26119","volume":"233","author":"JD Zhou","year":"2017","unstructured":"Zhou JD, Lin J, Zhang TJ, Ma JC, Li XX, Wen XM, et al. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia. J Cell Physiol. 2017;233:2444\u201350.","journal-title":"J Cell Physiol"},{"key":"146_CR27","doi-asserted-by":"crossref","first-page":"81452","DOI":"10.18632\/oncotarget.13263","volume":"7","author":"X Si","year":"2016","unstructured":"Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, et al. LncRNA H19 confers chemoresistance in ERalpha-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget. 2016;7:81452\u201362.","journal-title":"Oncotarget"},{"key":"146_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"E Raveh","year":"2015","unstructured":"Raveh E, Matouk IJ, Gilon M, Hochberg A. The H19 long non-coding RNA in cancer initiation, progression and metastasis\u2014a proposed unifying theory. Mol Cancer. 2015;14:184.","journal-title":"Mol Cancer"},{"key":"146_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000845","volume":"2","author":"IJ Matouk","year":"2007","unstructured":"Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2:e845.","journal-title":"PLoS One"},{"key":"146_CR30","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-16-3236","volume":"77","author":"M Rokavec","year":"2017","unstructured":"Rokavec M, Horst D, Hermeking H. Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with metastasis. Cancer Res. 2017;77:1854\u201367.","journal-title":"Cancer Res"},{"key":"146_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.234419.113","volume":"28","author":"BK Dey","year":"2014","unstructured":"Dey BK, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014;28:491\u2013501.","journal-title":"Genes Dev"},{"key":"146_CR32","doi-asserted-by":"publisher","first-page":"29209","DOI":"10.18632\/oncotarget.4976","volume":"6","author":"C Vennin","year":"2015","unstructured":"Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6:29209\u201323.","journal-title":"Oncotarget"},{"key":"146_CR33","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1002\/stem.2225","volume":"33","author":"Y Huang","year":"2015","unstructured":"Huang Y, Zheng Y, Jia L, Li W. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-beta1\/Smad3\/HDAC Signaling Pathway by Deriving miR-675. Stem Cells. 2015;33:3481\u201392.","journal-title":"Stem Cells"},{"key":"146_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.29209","volume":"66","author":"Y Song","year":"2017","unstructured":"Song Y, Liu C, Liu X, Trottier J, Beaudoin M, Zhang L, et al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM. Hepatology. 2017;66:1183\u201396.","journal-title":"Hepatology"},{"key":"146_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10221","volume":"6","author":"J Zhou","year":"2015","unstructured":"Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, et al. H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nat Commun. 2015;6:10221.","journal-title":"Nat Commun"},{"key":"146_CR36","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1007\/s13277-014-2168-6","volume":"35","author":"G Cui","year":"2014","unstructured":"Cui G, Cui M, Li Y, Liang Y, Li W, Guo H, et al. MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35:8933\u20137.","journal-title":"Tumour Biol: J Int Soc Oncodev Biol Med"},{"key":"146_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-82","volume":"14","author":"K Erdmann","year":"2014","unstructured":"Erdmann K, Kaulke K, Thomae C, Huebner D, Sergon M, Froehner M, et al. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer. 2014;14:82.","journal-title":"BMC Cancer"},{"key":"146_CR38","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/carcin\/bgt158","volume":"34","author":"H Li","year":"2013","unstructured":"Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N, et al. PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis. 2013;34:2145\u201355.","journal-title":"Carcinogenesis"},{"key":"146_CR39","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3109\/10428194.2012.763123","volume":"54","author":"G Ferrer","year":"2013","unstructured":"Ferrer G, Navarro A, Hodgson K, Aymerich M, Pereira A, Baumann T, et al. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia. Leuk Lymphoma. 2013;54:2016\u201322.","journal-title":"Leuk Lymphoma"},{"key":"146_CR40","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1159\/000369669","volume":"34","author":"J Ma","year":"2014","unstructured":"Ma J, Lin J, Qian J, Qian W, Yin J, Yang B, et al. MiR-378 promotes the migration of liver cancer cells by down-regulating Fus expression. Cell Physiol Biochem: Int J Exp Cell Physiol, Biochem, Pharmacol. 2014;34:2266\u201374.","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol, Biochem, Pharmacol"},{"key":"146_CR41","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/jcp.26119","volume":"233","author":"JD Zhou","year":"2018","unstructured":"Zhou JD, Lin J, Zhang TJ, Ma JC, Li XX, Wen XM, et al. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia. J Cell Physiol. 2018;233:2444\u201350.","journal-title":"J Cell Physiol"},{"key":"146_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1096\/fj.03-0545fje","volume":"18","author":"PS Zheng","year":"2004","unstructured":"Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, et al. Versican\/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J. 2004;18:754\u20136.","journal-title":"FASEB J"},{"key":"146_CR43","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1038\/onc.2016.15","volume":"35","author":"S Bernaudo","year":"2016","unstructured":"Bernaudo S, Salem M, Qi X, Zhou W, Zhang C, Yang W, et al. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt\/beta-catenin signaling. Oncogene. 2016;35:4816\u201327.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0146-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:29Z","timestamp":1684617029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0146-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":43,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0146-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}